About FDA
Number of highest risk products domestic inspections completed in a month
Cumulative FY 2011 Performance Goal Target: 10,607
Dictionary: A high risk firm is a firm that is producing a food product that may present a high potential for harm if consumed when the food has been prepared under inadequate conditions such as improper processing, storage, handing and distribution.. From this high-risk list, ORA creates a workplan of high-risk inspections to complete for the year.
Fiscal Year - 2011
Cumulative FY 2011 Performance Goal Target: 10,607
| Time | Monthly Guideline to Reach Cumulative FY 2011 Performance Goal Target | Number |
|---|---|---|
| Oct 2010 | 705 | 929 |
| Nov 2010 | 708 | 1,141 |
| Dec 2010 | 708 | 1,136 |
| Jan 2011 | 1,059 | 914 |
| Feb 2011 | 1,062 | 928 |
| Mar 2011 | 1,063 | 1,346 |
| Apr 2011 | 1,058 | 945 |
| May 2011 | 1,062 | 1,083 |
| Jun 2011 | 1,063 | 1,198 |
| Jul 2011 | 705 | 738 |
| Aug 2011 | 707 | 993 |
| Sep 2011 | 707 | 777 |
FY 2011 Total: 12,128
Cumulative annual highest risk product domestic inspections completed by the end of the month
Cumulative FY 2011 Performance Goal Target: 10,607
Fiscal Year - 2011
Cumulative FY 2011 Performance Goal Target: 10,607
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 929 |
| Nov 2010 | N/A | 2,070 |
| Dec 2010 | N/A | 3,206 |
| Jan 2011 | N/A | 4,120 |
| Feb 2011 | N/A | 5,048 |
| Mar 2011 | N/A | 6,394 |
| Apr 2011 | N/A | 7,339 |
| May 2011 | N/A | 8,422 |
| Jun 2011 | N/A | 9,620 |
| Jul 2011 | N/A | 10,358 |
| Aug 2011 | N/A | 11,351 |
| Sep 2011 | N/A | 12,128 |
Cumulative percent of annual highest risk product domestic inspections completed at the end of the month
Fiscal Year - 2011
| Time | Target | Cumulative Percent |
|---|---|---|
| Oct 2010 | N/A | 9 |
| Nov 2010 | N/A | 20 |
| Dec 2010 | N/A | 30 |
| Jan 2011 | N/A | 39 |
| Feb 2011 | N/A | 48 |
| Mar 2011 | N/A | 60 |
| Apr 2011 | N/A | 69 |
| May 2011 | N/A | 79 |
| Jun 2011 | N/A | 91 |
| Jul 2011 | N/A | 98 |
| Aug 2011 | N/A | 107 |
| Sep 2011 | N/A | 114 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
